Unjoni Ewropea - Malti - EMA (European Medicines Agency)

zoetis belgium sa - pirlimycin - antibacterials għal użu intramammarju - bhejjem - għat-trattament ta sottoklinika mastite fil-baqar li jkunu qed ireddgħu minħabba li gram-pożittivi imma suxxettibbli għall-pirlimycin inkluż stafilokokkal organiżmi bħal staphylococcus aureus, kemm l-penicillinase-positive u penicillinase-negative u coagulase-negative staphylococci; streptococcal organiżmi inkluż streptococcus agalactiae, streptococcus dysgalactiae u streptococcus uberis.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), poliovirus (inactivated) (type 1 (mahoney strain), type 2 (mef-1 strain), type 3 (saukett strain)), hepatitis b surface antigen - hepatitis b; tetanus; immunization; whooping cough; poliomyelitis; diphtheria - vaċċini - infanrix penta huwa indikat għall-vaċċinazzjoni primarja u booster tat-trabi kontra diphtheria, tetanus, pertussis, epatite b u poliomyelitis.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - dalbavancin hydrochloride - soft tissue infections; skin diseases, bacterial - antibatteriċi għal użu sistemiku, - trattament tal-ġilda akuta batterjali u infezzjonijiet ta ' l-istruttura ta ' ġilda (absssi) fl-adulti.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - oritavancin (diphosphate) - soft tissue infections; skin diseases, bacterial - antibatteriċi għal użu sistemiku, - tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and paediatric patients aged 3 months and older (see sections 4. 2, 4. 4 u 5. għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

sanofi pasteur - hepatitis b surface antigen, diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens pertussis toxoid filamentous haemagglutinin, poliovirus (inactivated) type 1 (mahoney) type 2 (mef-1) type 3 (saukett), haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines, bacterial and viral vaccines, combined - hexacima (dtap-ipv-hb-hib) huwa indikat għat-tilqim primarja u booster tat-trabi u toddlers minn sitt ġimgħat ta ' età kontra diphtheria, tetanus, pertussis, epatite b, poliomyelitis u invażivi mard ikkawżat minn influwenza Ħemofillika tip b (hib). l-użu ta ' dan il-vaċċin għandha tkun skond ir-rakkomandazzjonijiet uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

sanofi pasteur europe - filamentous haemagglutinin, haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate), hepatitis b surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (mahoney strain) produced on vero cells, poliovirus (inactivated) type 2 (mef-1 strain) produced on vero cells, poliovirus (inactivated) type 3 (saukett strain) produced on vero cells, tetanus protein, tetanus toxoid adsorbed on aluminium hydroxide, hydrated, diphtheria toxoid - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaċċini - hexyon (dtap-ipv-hb-hib) huwa indikat għat-tilqim primarja u booster tat-trabi u toddlers minn sitt ġimgħat ta ' età kontra diphtheria, tetanus, pertussis, epatite b, poliomyelitis u invażivi mard ikkawżat minn influwenza Ħemofillika tip b (hib). l-użu ta ' dan il-vaċċin għandha tkun skond ir-rakkomandazzjonijiet uffiċjali.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaċċini - infanrix hexa huwa indikat għall-vaċċinazzjoni primarja u booster tat-trabi kontra diphtheria, tetanus, pertussis, epatite b, poliomyelitis u mard ikkawżat minn influwenza Ħemofillika tip-b.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

theravance biopharma ireland umited - telavancin - pneumonia, bacterial; cross infection - antibatteriċi għal użu sistemiku, - vibativ huwa indikat għat-trattament ta ' l-adulti bl-pnewmonja nosokomjali inklużi ventilaturi assoċjati pnewmonja, magħrufa jew issuspettat li jkun ikkawżat mill-awrei-reżistenti staphylococcus aureus (mrsa). vibativ għandu jintuża biss f'sitwazzjonijiet fejn huwa magħruf jew hemm suspett li l-alternattivi oħra mhumiex adattati. għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - immunization; hepatitis b; hepatitis a - vaċċini - twinrix pediatric huwa indikat għall-użu fi trabi mhux immuni, tfal u adolexxenti minn sena sa u li jinkludu 15-il sena li huma f'riskju kemm ta 'infezzjoni ta' l-epatite-a kif ukoll ta 'l-epatite-b.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

mcm vaccine b.v. - toxoid tad-difterite, toxoid tat-tetnu, bordetella-antiġeni tal-pertussis: toxoid tal-pertussis, filamentużi haemagglutinin, pertactin, fimbriae tipi 2 u 3, l-epatite b-antiġen tal-wiċċ prodott f'ċelloli tal-ħmira, poliovirus (inattivat): tat-tip 1 (mahoney), it-tip 2 (mef-1), it-tip 3 (saukett) prodott f'ċelloli vero/ haemophilus influenzae tat-tip b polysaccharide (polyribosylribitol phosphate) konjugat meningokokkali-proteina. - meningitis, haemophilus; poliomyelitis; tetanus; diphtheria; whooping cough; hepatitis b - vaċċini - vaxelis (dtap-hb-ipv-hib) huwa indikat għall-vaċċinazzjoni primarja u booster fit-trabi u toddlers mill-età ta ' 6 ġimgħat, kontra diphtheria, tetanus, pertussis, epatite b, poliomyelitis u invażivi mard ikkawżat minn influwenza Ħemofillika tip b (hib). l-użu ta 'vaxelis għandu jkun skond ir-rakkomandazzjonijiet uffiċjali.